RTTNews Top Stories

206.5K posts

RTTNews Top Stories banner
RTTNews Top Stories

RTTNews Top Stories

@RTTNews

RTTNews delivers all the important global financial news, Market analysis, Economic news, stock alerts, forex news.

Worldwide Beigetreten Ekim 2009
707 Folgt4.1K Follower
RTTNews Top Stories
RTTNews Top Stories@RTTNews·
a landmark CAR T-cell therapy in autoimmune disease. When KYTX was profiled on our site on September 30, 2025, it was trading at $5.86. The stock subsequently rallied over the following months, reaching a 52-week high of $13.67 on December 15, 2025, before... (4/5)
English
1
0
0
37
RTTNews Top Stories
RTTNews Top Stories@RTTNews·
2 registrational trial of Miv-cel in stiff person syndrome, along with longer-term follow-up data from the KYSA-6 Phase 2 trial in generalized myasthenia gravis (gMG). Miv-cel is a fully human, autologous CD19-targeting CAR-T cell therapy with CD28 co-stimulation. (2/5)
English
0
1
1
29
RTTNews Top Stories
RTTNews Top Stories@RTTNews·
𝗪𝗶𝗹𝗹 𝗞𝘆𝘃𝗲𝗿𝗻𝗮 𝗺𝗮𝗸𝗲 𝗵𝗶𝘀𝘁𝗼𝗿𝘆? Kyverna Therapeutics, Inc. (KYTX) is set to host a conference call on Wednesday, April 22, 2026, at 7:00 a.m. ET to discuss key pipeline updates. The company will present primary analysis from its KYSA-8 Phase... (1/5)
RTTNews Top Stories tweet media
English
1
0
0
54